Edmund K. Bartlett

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 15 papers. Top paper: “Objective Response Rate Among Patients With Locally Advanced or Metastatic Sarcoma Treated With Talimogene Laherparepvec in Combination With Pembrolizumab”.

Objective Response Rate Among Patients With Locally Advanced or Metastatic Sarcoma Treated With Talimogene Laherparepvec in Combination With Pembrolizumab

JAMA Oncology(2020)10.1001/jamaoncol.2019.6152

N/A

5.0DataRank · unranked

207 citations

Cristina R. Antonescu, Timothy G. Bowler, Rodrigo Ramella Munhoz, Ping Chi, Mark A. Dickson +21 more

Neoadjuvant relatlimab and nivolumab in resectable melanoma

Nature(2022)10.1038/s41586-022-05368-8

N/A

0.874DataRank · unranked

339 citations

Michael A. Postow, Elizabeth M. Burton, Michael T. Tetzlaff, Merrick I. Ross, Carlos A. Torres‐Cabala +35 more

Performance of Gene Expression Profile Tests for Prognosis in Patients With Localized Cutaneous Melanoma

JAMA Dermatology(2020)10.1001/jamadermatol.2020.1731

N/A

0.609DataRank · unranked

57 citations

Daniel G. Coit, Stephen W. Dusza, Ashley Yu, LaToya McLean, Yinin Hu +5 more

Undifferentiated and Dedifferentiated Metastatic Melanomas Masquerading as Soft Tissue Sarcomas: Mutational Signature Analysis and Immunotherapy Response

Modern Pathology(2023)10.1016/j.modpat.2023.100165

N/A

0.564DataRank · unranked

42 citations

Walid K. Chatila, Cecilia Lezcano, Christopher A. Febres‐Aldana, Nikolaus Schultz, Chad Vanderbilt +10 more

Timing of Adjuvant Immunotherapy in Stage III Melanoma, Does it Matter?

Annals of Surgical Oncology(2023)10.1245/s10434-023-13935-0

N/A

0.515DataRank · unranked

9 citations

Sin‐Ho Jung, Kelly M. Elleson, Danielle K. DePalo, Richard J. Straker, Sophia K. McKinley +11 more

Case Report: Response to Regional Melphalan via Limb Infusion and Systemic PD1 Blockade in Recurrent Myxofibrosarcoma: A Report of 2 Cases

Frontiers in Oncology(2021)10.3389/fonc.2021.725484

N/A

0.484DataRank · unranked

9 citations

Sandra P. D’Angelo, Ciara M. Kelly, Robert H. Siegelbaum, Charles Fisher, Cristina R. Antonescu +2 more

Contemporary trends in utilization of metastasectomy in the era of targeted and immunotherapies

Cancer(2024)10.1002/cncr.35664

N/A

0.208DataRank · unranked

3 citations

Michael J. Kallan, Jeffrey L. Roberson, Sara P. Ginzberg, Wajid Amjad, Jacqueline M. Soegaard Ballester +6 more

Author Correction: Neoadjuvant relatlimab and nivolumab in resectable melanoma

Nature(2023)10.1038/s41586-023-05892-1

N/A

0.165DataRank · unranked

2 citations

Michael A. Postow, Elizabeth M. Burton, Michael T. Tetzlaff, Merrick I. Ross, Carlos A. Torres‐Cabala +35 more

Regional control after precision lymph node dissection for clinically evident melanoma metastasis

Journal of Surgical Oncology(2022)10.1002/jso.27100

N/A

0.165DataRank · unranked

2 citations

Yinin Hu, Norma E. Farrow, Yun Song, Max O. Meneveau, Minyoung Kwak +6 more

Clinically Significant Risk Thresholds in the Management of Primary Cutaneous Melanoma: A Survey of Melanoma Experts

Annals of Surgical Oncology(2022)10.1245/s10434-022-11869-7

N/A

0DataRank · unranked

6 citations

Douglas Grossman, Susan M. Swetter, Sancy A. Leachman, Clara Curiel‐Lewandrowski, Stephen W. Dusza +6 more

Immunologic correlates in a CIC::DUX4 fusion-positive sarcoma responsive to dual immune checkpoint blockade

npj Precision Oncology(2025)10.1038/s41698-025-00878-w

N/A

0DataRank · unranked

2 citations

Sara Coca Membribes, Cristina Anthonescu, Martina Bradić, Bernard O’Malley, Irina Linkov +9 more

A Phase II Study of Epacadostat and Pembrolizumab in Patients with Advanced Sarcoma

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3911

N/A

0DataRank · unranked

69 citations

Li‐Xuan Qin, Karissa Whiting, Allison L. Richards, Viswatej Avutu, Jason E. Chan +18 more

Are the MIA and MSKCC nomograms useful in selecting patients with melanoma for sentinel lymph node biopsy?

Journal of Surgical Oncology(2023)10.1002/jso.27231

N/A

0DataRank · unranked

22 citations

Harrison Drebin, Nicholas R. Kurtansky, Roger Olofsson Bagge, Daniel G. Coit, Edmund K. Bartlett +2 more

Clinical Utility of Melanoma Sentinel Lymph Node Biopsy Nomograms

Journal of the American College of Surgeons(2023)10.1097/xcs.0000000000000886

N/A

0DataRank · unranked

12 citations

Sharif Hosein, Nicholas R. Kurtansky, Emily R. Nadelmann, Andrea P. Moy, Charlotte E. Ariyan +6 more

1762P Utility of circulating tumor DNA (ctDNA) as a molecular biomarker in the phase II trial of imatinib plus binimetinib in patients with treatment-naïve, advanced gastrointestinal stromal tumor (GIST)

Annals of Oncology(2024)10.1016/j.annonc.2024.08.1853

N/A

0DataRank · unranked

0 citations

Martina Bradić, Sara Saunds, V. Avutu, Jason W. Chan, Sandra P. D’Angelo +15 more